
    
      This is a randomized double-blinded placebo-controlled intervention trial investigating
      preeclampsia, defined according to the International Society for the Study of Hypertension in
      Pregnancy (ISSHP). The population of interest involves pregnant women diagnosed with
      pre-eclampsia at a gestational age between 28 and 32 weeks at Aswan university hospital will
      be invited to participate. To be enrolled, the treating team needs to have determined after
      their initial assessment that delivery is unlikely to be required within 48 h. A starting
      point of 28 weeks has been chosen as this would be the earliest gestation that Aswan
      university hospital to be viable and are suitable to be offered expectant management The
      intervention involves randomization to oral esomeprazole tablets40 mg plus metformin tablets
      1000 mg or identical placebo tablets from recruitment until delivery. Randomization is
      achieved using computational random allocation, and both participants and researchers will be
      blinded to the intervention given.
    
  